Advanced search
Publication Cover
Expert Review of Gastroenterology & Hepatology Volume 10, 2016 - Issue 2
Submit an article Journal homepage
673
Views
31
CrossRef citations to date
0
Altmetric
Reviews

The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update

Salvatore SuttiDepartment of Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University “Amedeo Avogadro” of East Piedmont, Novara, Italy
,
Stefania BruzzìDepartment of Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University “Amedeo Avogadro” of East Piedmont, Novara, Italy
&
Emanuele AlbanoDepartment of Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University “Amedeo Avogadro” of East Piedmont, Novara, ItalyCorrespondence[email protected]
Pages 243-253 | Received 27 Aug 2015, Accepted 20 Oct 2015, Published online: 03 Dec 2015

References

  • Papers of special note have been highlighted as:
  • * Of interest
  • ** Of considerable interest
  • Mathurin P, Bataller R. Trends in the management and burden of alcoholic liver disease. J Hepatol. 2015;62(1 Suppl):S38–S46.
  • Tzukamoto H. Conceptual importance of identifying alcoholic liver disease as a lifestyle disease. J Gastroenterol. 2007;42:603–609.
  • Satapathy SK, Sanyal AJ. Epidemiology and natural history of nonalcoholic fatty liver disease. Semin Liver Dis. 2015;35:221–235.
  • Rafiq N, Bai C, Fang Y, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7:234–238.
  • Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99–S112.
  • Yip WW, Burt AD. Alcoholic liver disease. Semin Diagn Pathol. 2006;23:149–160.
  • Yeh MM, Brunt EM. Pathological features of fatty liver disease. Gastroenterology. 2014;147:754–764.
  • Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148:547–555.
  • Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59:160–168.
  • Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol. 2012;56:1384–1391.
  • Stickel F. Alcoholic cirrhosis and hepatocellular carcinoma. Adv Exp Med Biol. 2015;815:113–130.
  • Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141:1572–1585.
  • Wang HJ, Gao B, Zakhari S, et al. Inflammation in alcoholic liver disease. Ann Rev Nutr. 2012;32:343–368.
  • Rosso N, Chavez-Tapia NC, Tiribelli C, et al. Translational approaches: from fatty liver to non-alcoholic steatohepatitis. World J Gastroenterol. 2014;20:9038–9049.
  • Hartmann P, Seebauer CT, Schnabl B. Alcoholic liver disease: the gut microbiome and liver cross talk. Alcohol Clin Exp Res. 2015;39:763–775.
  • Bieghs V, Trautwein C. Innate immune signaling and gut-liver interactions in nonalcoholic fatty liver disease. Hepatobiliary Surg Nutr. 2014;3:377–385.
  • Petrasek J, Csak T, Ganz M, et al. Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis. J Gastroenterol Hepatol. 2012;28(Suppl 1):82–93.
  • Mehal WZ. The inflammasome in liver injury and non-alcoholic fatty liver disease. Dig Dis. 2014;32:507–515.
  • Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol. 2015;12:387–400.
  • Albano E. Oxidative stress in alcoholic liver disease. In: Albano E, Parola M, editors. Oxidative stress in applied basic research and clinical practice: studies on hepatic disorders. Basel: Humana Press, Springer International Publishing; 2015. p. 215–239.
  • Gambino R, Musso G, Cassader M. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid Redox Signal. 2011;15:1325–1365.
  • Miller YI, Choi SH, Weisner P, et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res. 2011;108:235–248.
  • Weismann D, Binder CJ. The innate immune response to products of phospholipid peroxidation. Biochim Biophys Acta. 2012;1818:2465–2475.
  • Albano E. Role of adaptive immunity in alcoholic liver disease. Int J Hepatol. 2012;2012:893026. DOI:10.1155/2012/893026.
  • Lemmers A, Moreno C, Gustot T, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009;49:646–657.
  • Klassen LW, Tuma D, Sorrell MF. Immune mechanisms of alcohol-induced liver disease. Hepatology. 1995;22:355–357.
  • Vidali M, Stewart SF, Albano E. Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury. Trends Mol Med. 2008;14:63–71.
  • Sutti S, Rigamonti C, Vidali M, et al. CYP2E1 autoantibodies in liver diseases. Redox Biol. 2014;3:72–78.
  • Gadd VL, Skoien R, Powell EE, et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology. 2014;59:1393–1405.
  • Sutti S, Jindal A, Locatelli I, et al. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology. 2014;59:886–897.

** The paper is the first demonstration that adaptive immune responses against oxidative stress-derived antigens have a role in the evolution of steatohepatitis in a mice model of nonalcoholic steatohepatitis

  • Weston CJ, Shepherd EL, Claridge LC. Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis. J Clin Invest. 2015;125:501–520.
  • Wolf MJ, Adili A, Piotrowitz K, et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell. 2014;26:549–564.

** This paper provides extensive evidence supporting the role of CD8+ T-lymphocytes and natural killer T cells in the evolution of nonalcoholic steatohepatitis and in the development of nonalcoholic steatohepatitis-related hepatocellular carcinoma in mice

  • Inzaugarat ME, Ferreyra Solari NE, et al. Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis. J Clin Immunol. 2011;31:1120–1130.
  • Ferreyra Solari NE, Inzaugarat ME, et al. The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis. J Clin Immunol. 2012;32:611–621.
  • Tang Y, Bian Z, Zhao L, et al. Inteleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease. Clin Exp Immunol. 2011;166:281–290.
  • Sell H, Habich C, Eckel J. Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol. 2012;8:709–716.
  • Leibundgut G, Witztum JL, Tsimikas S. Oxidation-specific epitopes and immunological responses: translational biotheranostic implications for atherosclerosis. Curr Opin Pharmacol. 2013;13:168–179.
  • Stewart SF, Vidali M, Day CP, et al. Oxidative stress as a trigger for cellular immune response in patients with alcoholic liver disease. Hepatology. 2004;39:197–203.
  • Thiele GM, Klassen LW, Tuma DJ. Formation and immunological properties of aldehyde-derived protein adducts following alcohol consumption. Methods Mol Biol. 2008;447:235–257.
  • Thiele GM, Duryee MJ, Willis MS, et al. Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites. Alcohol Clin Exp Res. 2010;34:2126–2136.
  • Albano E, Mottaran E, Vidali M, et al. Immune response toward lipid peroxidation products as a predictor of the progression of non-alcoholic fatty liver disease (NAFLD) to advanced fibrosis. Gut. 2005;54:987–993.
  • Nobili V, Parola M, Alisi A, et al. Oxidative stress parameters in paediatric non-alcoholic fatty liver disease. Int J Mol Med. 2010;26:471–476.
  • Anderson DR, Duryee MJ, Shurmur SW, et al. Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease. PLoS One. 2012;9:e107440. DOI:10.1371/journal.pone.01074402014.
  • Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47–S64.
  • Baumgardner JN, Shankar S, Hennings L, et al. N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis. J Nutr. 2008;138:1872–1879.
  • Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592–1609.
  • Vidali M, Hietala J, Occhino G, et al. Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-α and accelerated liver damage in heavy drinkers. Free Rad Biol Med. 2008;45:306–311.
  • Lou XY, Takara T, Kawai K, et al. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine-and choline-deficient high fat diet. Am J Physiol Gastroinstest Liver Physiol. 2013;305:G891–G899.

* This paper demonstrates the role of IFN-γ in sustaining the evolution of steatohepatitis in a mice model of nonalcoholic steatohepatitis

  • Shimazu Y, Hamaguchi M, Fukuda T, et al. Steatohepatitis as impaired immune metabolism induced by liver resident regulatory T-cell depletion. Hepatology. 2015. DOI:10.1002/hep.27986.

** This paper provides the first demonstration of the importance of regulatory T-cells in the pathogenesis of nonalcoholic steatohepatitis

  • Crispe IN. Immune tolerance in liver disease. Hepatology. 2014;60:2109–2117.
  • Rensen SS, Slaats Y, Driessen A, et al. Activation of complement system in human non-alcoholic fatty liver disease. Hepatology. 2009;50:1809–1817.
  • Bieghs V, van Gorp PJ, Walenbergh SM, et al. Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice. Hepatology. 2012;56:894–903.
  • Tsiantoulas D, Diehl CJ, Witztum JL, et al. B cells and humoral immunity in atherosclerosis. Circ Res. 2014;114:1743–1756.
  • Wang H, Yin S. Natural killer T cells in liver injury, inflammation and cancer. Expert Rev Gastroenterol Hepatol. 2015;9:1077–1085.
  • Kremer M, Thomas E, Milton RJ, et al. Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis. Hepatology. 2010;51:130–141.
  • Tang ZH, Liang S, Potter J, et al. Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease. J Immunol. 2013;190:1788–1796.
  • Tajiri K, Shimizu Y, Tsuneyama K, et al. Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2009;21:673–680.
  • Syn WK, Agboola KM, Swiderska M, et al. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut. 2012;61:1323–1329.
  • Maricic I, Sheng H, Marrero I, et al. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice. Hepatology. 2015;61:1357–1369.
  • Cui K, Yan G, Xu C, et al., et al. Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice. J Hepatol. 2015;62:1311–1318.

* The paper characterizes one of the mechanisms by which natural killer T cells support alcohol-induced hepatic inflammation

  • Locatelli I, Sutti S, Vacchiano M, et al. NF-kB1 deficiency stimulates the progression of nonalcoholic steatohepatitis (NASH) in mice by promoting NKT-mediated responses. Clin Sci (Lond). 2013;124:279–287.
  • Wehr A, Baeck C, Heymann F, et al. Chemokine receptor CXCR6-dependent hepatic NK T cell accumulation promotes inflammation and liver fibrosis. J Immunol. 2013;190:5226–5236.
  • Gordy LE, Bezbradica JS, Flyak AI, et al. IL-15 regulates homeostasis and terminal maturation of NKT cells. J Immunol. 2011;187:6335–6345.
  • Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol. 2013;14:996–1006.
  • Schildberg FA, Sharpe AH, Turley SJ. Hepatic immune regulation by stromal cells. Curr Opinion Immunol. 2015;32:1–6.
  • Heymann F, Peusquens J, Ludwig-Portugall I, et al. Liver inflammation abrogates immunological tolerance induced by Kupffer cells. Hepatology. 2015;62:279–291.

* The paper shows that Kupffer cells have an important role in maintaining immune tolerance within the liver and that Kupffer cell activation abrogates these effects

  • Ma X, Hua J, Mohamood AR, et al. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology. 2007;46:1519–1529.
  • Tselios K, Sarantopoulos A, Gkougkourelas I, et al. T regulatory cells: a promising new target in atherosclerosis. Crit Rev Immunol. 2014;34:389–397.
  • Eckert C, Klein N, Kornek M, et al. The complex myeloid network of the liver with diverse functional capacity at steady state and in inflammation. Front Immunol. 2015;20:179. DOI:10.3389/fimmu.2015.00179.
  • Rahman AH, Aloman C. Dendritic cells and liver fibrosis. Biochim Biophys Acta. 2013;1832:998–1004.
  • Ibrahim J, Nguyen AH, Rehman A, et al. Dendritic cell populations with different concentrations of lipids regulates tolerance and immunity in mouse and human liver. Gastroentrology. 2012;143:1061–1072.
  • Henning JR, Graffeo CS, Rehman A, et al. Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice. Hepatology. 2013;58:589–602.

* This paper demonstrates that hepatic dendritic cells have a role in the pathogenesis of nonalcoholic steatohepatitis

  • Sutti S, Locatelli I, Bruzzì S, et al. CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis. Clin Sci (Lond). 2015;129:797–808.
  • Domininguez PM, Ardavin C. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev. 2010;234:90–104.
  • Seijkens T, Kusters P, Chatzigeorgiou A, et al. Immune cell crosstalk in obesity: a key role for costimulation? Diabetes. 2014;63:3982–3991.
  • Chatzigeorgiou A, Chung KJ, Garcia-Martin R, et al. Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation. Hepatology. 2014;60:1196–1210.
  • Weiner HL, Pies da Cunha A, Quintana F, et al. Oral tolerance. Immunol Rev. 2011;241:241–259.
  • Foks AC, Lichtman AH, Kuiper J. Treating atherosclerosis with regulatory T cells. Arterioscler Thromb Vasc Biol. 2015;35:280–287.
  • Ilan Y, Maron R, Tukpah AM, et al. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci U S A. 2010;107:9765–9770.
  • Ilan Y, Zigmond E, Lalazar G, et al. Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells. J Clin Immunol. 2010;30:167–177.
  • Lalazar G, Mizrahi M, Turgeman I, et al. Oral administration of OKT3 MAb to patients with NASH, promotes regulatory T-cell induction, and alleviates insulin resistance: results of a phase IIa blinded placebo-controlled trial. J Clin Immunol. 2015;35:399–407.
  • Mizrahi M, Shabat Y, Ben Ya’acov A, et al. Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH. J Inflamm Res. 2012;5:141–150.
  • Adar T, Ben Ya’acov A, Lalazar G, et al. Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells. Clin Exp Immunol. 2012;167:252–260.
  • Kim KS, Surh CD. Induction of immune tolerance to dietary antigens. Adv Exp Med Biol. 2015;850:93–118.
  • Elinav E, Pappo O, Sklair-Levy M, et al. Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels. J Pathol. 2006;208:74–81.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.